Crying out for equity: outcomes of rheumatic diseases confounded by ethnicity Shirish DubeyAdewale O. Adebajo Editorial 19 July 2022 Pages: 2621 - 2624
Functional manifestations of early knee osteoarthritis: a systematic review and meta-analysis Hiroki ShimizuKanako ShimouraTomoki Aoyama Review Article 12 May 2022 Pages: 2625 - 2634
Physical exercise for dermatomyositis and polymyositis: a systematic review and meta-analysis Beatriz Iwamoto Sercundes Leite da SilvaBeatriz Roberto Jorge dos SantosJean Marcos de Souza Review Article 12 July 2022 Pages: 2635 - 2646
The association between dietary inflammation index and the risk of rheumatoid arthritis in Americans Shate XiangYao WangTaotao Xu Original Article 28 May 2022 Pages: 2647 - 2658
Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologists Jiu Liang ZhaoXin LiuXiao Feng Zeng Original Article 17 May 2022 Pages: 2659 - 2668
Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study Mary N. EzeanunaDavid K. PrinceNamrata Singh Original Article 25 May 2022 Pages: 2669 - 2676
Comparison and correlation study of synovial ultrasound indices and serum VEGF in rheumatoid wrist arthritis before and after treatment Yan-fen ZhangShan-shan GaoYao-cheng Xiao Original Article 27 May 2022 Pages: 2677 - 2683
Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors Jianjun QiuChunde LuHanlin Zou Original Article 07 June 2022 Pages: 2685 - 2693
Real-world single-centre experience of rheumatoid arthritis patients requiring four or more higher cost drugs: response and duration of treatment David WalkerIain GoffSandra Robinson Original Article 07 June 2022 Pages: 2695 - 2700
Oral methotrexate at doses 15–25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis Fang WangJingliang TangFang Wang Original Article 07 June 2022 Pages: 2701 - 2712
Reliability and validity of the Chinese version of the eight-item Morisky Medication Adherence Scale in Chinese patients with systemic lupus erythematosus Pei-Li ShiZhen-Zhen WuGuo-Cui Wu Original Article 10 May 2022 Pages: 2713 - 2720
Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus Sulaiman M. Al-MayoufLujayn AkbarAlhanouf Alsaleem Original Article 19 May 2022 Pages: 2721 - 2727
Clinicopathological significance of tubulointerstitial CD68 macrophages in proliferative lupus nephritis Jiejian ChenLinlin CuiWeijia Xu Original Article 26 May 2022 Pages: 2729 - 2736
Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosus Pamela Munguía-RealpozoMario García-CarrascoLuis H. Silveira Original Article 27 May 2022 Pages: 2737 - 2743
The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study Annelie BilbergIngrid LarssonEva Klingberg Original Article Open access 01 June 2022 Pages: 2745 - 2754
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis Chiara PellicanoRoberta CampagnaEdoardo Rosato Original Article Open access 26 May 2022 Pages: 2755 - 2763
Exploration of the pathogenesis of Sjögren’s syndrome via DNA methylation and transcriptome analyses Yu DuJie LiChengsong He Original Article 13 May 2022 Pages: 2765 - 2777
Mapping theme trends and knowledge structure of Sjögren’s syndrome (SS), a bibliometric analysis from 2010 to 2021 Yi LiuBowen ZhengYi Liu Original Article 14 May 2022 Pages: 2779 - 2789
Elevated CXCL13 in primary Sjögren’s syndrome and its correlation with disease activity: a systematic review and meta-analysis Tong ZhuZijian PanNannan Zhang Original Article 26 May 2022 Pages: 2791 - 2802
Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital Takeshi SugaHiroshi OiwaYasuo Iwamoto Brief Report 11 April 2022 Pages: 2803 - 2808
Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort Fabián Carranza-EnríquezJosé Antonio Meade-AguilarAndrea Hinojosa-Azaola Brief Report 04 May 2022 Pages: 2809 - 2816
Short-term, low-dose etoposide in refractory adult-onset Still’s disease-associated macrophage activation syndrome Ran WangTing LiQiong Fu Original Article 19 May 2022 Pages: 2817 - 2823
Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis Emma J. SumnerBeverley AlmeidaElizabeth Ralph Brief Report Open access 29 April 2022 Pages: 2825 - 2830
An evaluation of sleep habits and childhood-onset systemic lupus erythematosus Gizem DurcanSezgin SahinOzgur Kasapcopur Original Article 31 May 2022 Pages: 2831 - 2837
Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic Hart A. GoldharUmmugulsum GazelSibel Zehra Aydin Brief Report 05 May 2022 Pages: 2839 - 2844
In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant Florence AssanPierre BayMarc Pineton de Chambrun Original Article 10 May 2022 Pages: 2845 - 2854
Gonococcal arthritis: case series of 58 hospital cases Aurore MoussiegtClaire FrançoisLoïc Raffray Original Article 20 May 2022 Pages: 2855 - 2862
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA Theresa HunterMichael GrabnerJeffrey R. Curtis Original Article 07 June 2022 Pages: 2863 - 2874
Amiodarone-induced cutaneous leukocytoclastic vasculitis: a case report and a review of the literature Tumay AkRumeysa Nur AlganZafer Turkoglu Case Based Review 02 June 2022 Pages: 2875 - 2881
Childhood-onset Takayasu arteritis and immunodeficiency: case-based review Seher SenerOzge BasaranSeza Ozen Case Based Review 20 July 2022 Pages: 2883 - 2892
Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management Pankti MehtaArmen Yuri GasparyanGeorge D. Kitas Perspectives in Rheumatology 31 May 2022 Pages: 2893 - 2910
Antiphospholipid syndrome presenting with inferior mesenteric vein thrombosis and associated rectal edema in a patient with systemic lupus erythematosus Timothy S. H. KwokAdriano Basso DiasKorosh Khalili Clinical Image 12 May 2022 Pages: 2911 - 2912
Systemic sarcoidosis with subcutaneous, muscular, cardiac, and lymph node involvement Takeshi ZoshimaHirofumi OkadaMitsuhiro Kawano Clinical Image 24 May 2022 Pages: 2913 - 2914
Lung cavitation in granulomatosis with polyangiitis: clinical implications David Bernal-BelloAlejandro Morales-OrtegaBegoña Frutos-Pérez Clinical Image 16 June 2022 Pages: 2915 - 2916
The VEXAS syndrome from rheumatology perspective: genomic DNA sequencing as available blueprint for diagnosing rheumatic diseases with overlapping haematological or dermatological findings Arvind NuneKarthikeyan P. IyengarCiro Manzo Letters of Biomedical and Clinical Research 17 May 2022 Pages: 2917 - 2918
Comments on: Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? By Jara et al Kunal Chandwar Letter to the Editor 19 July 2022 Pages: 2919 - 2919
In response to comment on “Autoimmune post‑COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?” by Jara LJ et al Luis J. JaraOlga Vera-LastraYehuda Shoenfeld Letter to the Editor 19 July 2022 Pages: 2921 - 2922
Correction to: Functional manifestations of early knee osteoarthritis: a systematic review and meta-analysis Hiroki ShimizuKanako ShimouraTomoki Aoyama Correction 14 June 2022 Pages: 2923 - 2923
